Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 29,201Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5Medichem S.A

02 4NanoAlvand

03 6Incyte Corporation

04 18Novartis Pharmaceuticals Australia Pty Limited

05 4Novartis Pharmaceuticals Corporation

06 3Novartis South Africa (Pty) Ltd

07 3ORIFARM GROUP AS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMedichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Regulatory Info :

Registration Country : Spain

Ruxolitinib Phosphate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 2MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

Medichem

02

arrow
CPhI India 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMedichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Regulatory Info :

Registration Country : Spain

Ruxolitinib Phosphate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

Medichem

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMedichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Regulatory Info :

Registration Country : Spain

Ruxolitinib Phosphate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

Medichem

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMedichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Regulatory Info :

Registration Country : Spain

Ruxolitinib Phosphate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

Medichem

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMedichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Regulatory Info :

Registration Country : Spain

Ruxolitinib Phosphate

Brand Name :

Dosage Form : Cream

Dosage Strength : 1.5%

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Spain

Medichem

07

arrow
CPhI India 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

08

arrow
CPhI India 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

09

arrow
CPhI India 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ruxolitinib Phosphate

Brand Name : Relata

Dosage Form : Tablet

Dosage Strength : 20MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

10

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 5MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

11

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

12

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

13

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

14

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : JAKAFI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 25MG BASE

Packaging :

Approval Date : 2011-11-16

Application Number : 202192

Regulatory Info : RX

Registration Country : USA

blank

15

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

RUXOLITINIB PHOSPHATE

Brand Name : OPZELURA

Dosage Form : CREAM;TOPICAL

Dosage Strength : EQ 1.5% BASE

Packaging :

Approval Date : 2021-09-21

Application Number : 215309

Regulatory Info : RX

Registration Country : USA

blank

16

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 10mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

17

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 15mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

18

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 20mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

19

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib

Brand Name : Jakavi

Dosage Form : Tablet

Dosage Strength : 5mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

20

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 15 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

21

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 20 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

22

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib Phosphate

Brand Name : Jakavi

Dosage Form : Antic-calc Tablet

Dosage Strength : 5 mg

Packaging : Blister

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

23

Novartis South Africa (Pty) Ltd

Country
CPhI India 2024
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib phosphate

Brand Name : Jakavi 20 mg

Dosage Form : TAB

Dosage Strength : 20mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

24

Novartis South Africa (Pty) Ltd

Country
CPhI India 2024
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib phosphate

Brand Name : Jakavi 15 mg

Dosage Form : TAB

Dosage Strength : 15mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

25

Novartis South Africa (Pty) Ltd

Country
CPhI India 2024
Not Confirmed
arrow

Novartis South Africa (Pty) Ltd

Country
arrow
CPhI India 2024
Not Confirmed

Ruxolitinib phosphate

Brand Name : Jakavi 5 mg

Dosage Form : TAB

Dosage Strength : 5mg

Packaging : 56X1mg

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

blank

26

Novartis Pharmaceuticals Australia ...

Country
CPhI India 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
CPhI India 2024
Not Confirmed

ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

27

Novartis Pharmaceuticals Australia ...

Country
CPhI India 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
CPhI India 2024
Not Confirmed

ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

28

Novartis Pharmaceuticals Australia ...

Country
CPhI India 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
CPhI India 2024
Not Confirmed

ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

29

Novartis Pharmaceuticals Australia ...

Country
CPhI India 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
CPhI India 2024
Not Confirmed

ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

30

Novartis Pharmaceuticals Australia ...

Country
CPhI India 2024
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
CPhI India 2024
Not Confirmed

ruxolitinib

Brand Name : Jakavi

Dosage Form :

Dosage Strength :

Packaging : 56

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank